title: A potential synergy between incomplete arsenic methylation capacity and demographic characteristics on the risk of hypertension: findings from a cross-sectional study in an arsenic-endemic area of inner Mongolia, China.
abstract: Inefficient arsenic methylation capacity has been associated with various health hazards induced by arsenic. In this study, we aimed to explore the interaction effect of lower arsenic methylation capacity with demographic characteristics on hypertension risk. A total of 512 adult participants (126 hypertension subjects and 386 non-hypertension subjects) residing in an arsenic-endemic area in Inner Mongolia, China were included. Urinary levels of inorganic arsenic (iAs), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA) were measured for all subjects. The percentage of urinary arsenic metabolites (iAs%, MMA%, and DMA%), primary methylation index (PMI) and secondary methylation index (SMI) were calculated to assess arsenic methylation capacity of individuals. Results showed that participants carrying a lower methylation capacity, which is characterized by lower DMA% and SMI, have a higher risk of hypertension compared to their corresponding references after adjusting for multiple confounders. A potential synergy between poor arsenic methylation capacity (higher MMA%, lower DMA% and SMI) and older age or higher BMI were detected. The joint effects of higher MMA% and lower SMI with cigarette smoking also suggest some evidence of synergism. The findings of present study indicated that inefficient arsenic methylation capacity was associated with hypertension and the effect might be enhanced by certain demographic factors.
authors.affiliation: Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, Shenyang 110013, China. liyongfang_17@163.com.
authors.forename: Yongfang
authors.initials: Y
authors.lastname: Li
authors.affiliation: Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, Shenyang 110013, China. wangda@mail.cmu.edu.cn.
authors.forename: Da
authors.initials: D
authors.lastname: Wang
authors.affiliation: Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, Shenyang 110013, China. lixin@mail.cmu.edu.cn.
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.affiliation: Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, Shenyang 110013, China. qmzheng@mail.cmu.edu.cn.
authors.forename: Quanmei
authors.initials: Q
authors.lastname: Zheng
authors.affiliation: Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, Shenyang 110013, China. sungf@mail.cmu.edu.cn.
authors.forename: Guifan
authors.initials: G
authors.lastname: Sun
mesh_terms: D000328:Adult; D000368:Aged; D001151:Arsenic / Q000378:metabolism / Q000633:toxicity*; D002681:China; D003430:Cross-Sectional Studies; D003710:Demography; D004785:Environmental Pollutants / Q000378:metabolism / Q000633:toxicity*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000378:metabolism; D008297:Male; D008745:Methylation; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D004785:Environmental Pollutants; D001151:Arsenic
references.citation: Environ Int. 2013 Mar;53:29-40
references.pmid: 23314041
references.citation: Sci Prog. 1999;82 ( Pt 1):69-88
references.pmid: 10445007
references.citation: Environ Health Perspect. 2012 May;120(5):623-6
references.pmid: 22336149
references.citation: Lancet. 2005 Jan 15-21;365(9455):217-23
references.pmid: 15652604
references.citation: Environ Health Perspect. 2007 Apr;115(4):648-52
references.pmid: 17450238
references.citation: Science. 2013 Aug 23;341(6148):866-8
references.pmid: 23970694
references.citation: Toxicol Appl Pharmacol. 2009 Mar 15;235(3):338-50
references.pmid: 19168087
references.citation: Int J Environ Res Public Health. 2014 Jul;11(7):7319-32
references.pmid: 25046631
references.citation: Environ Health Perspect. 2008 Dec;116(12):1661-5
references.pmid: 19079717
references.citation: Am J Public Health. 2004 Nov;94(11):1936-7
references.pmid: 15514231
references.citation: Hypertension. 1999 Jan;33(1):74-8
references.pmid: 9931084
references.citation: Eur J Epidemiol. 2005;20(7):563-4
references.pmid: 16119427
references.citation: Toxicol Appl Pharmacol. 2010 Sep 1;247(2):138-45
references.pmid: 20600216
references.citation: Toxicol Appl Pharmacol. 2000 Mar 1;163(2):203-7
references.pmid: 10698679
references.citation: J Occup Environ Med. 2006 May;48(5):478-88
references.pmid: 16688004
references.citation: Cardiovasc Toxicol. 2009 Dec;9(4):169-76
references.pmid: 19787300
references.citation: Arch Toxicol. 2000 Aug;74(6):289-99
references.pmid: 11005674
references.citation: Environ Health Perspect. 2012 Apr;120(4):494-500
references.pmid: 22138666
references.citation: Arch Toxicol. 2005 Apr;79(4):183-91
references.pmid: 15526190
references.citation: Toxicol Appl Pharmacol. 2007 Jan 15;218(2):99-106
references.pmid: 17196235
references.citation: Epidemiology. 1992 Sep;3(5):452-6
references.pmid: 1391139
references.citation: Bull Environ Contam Toxicol. 2007 Jun;78(6):455-8
references.pmid: 17619801
references.citation: Oncologist. 2001;6 Suppl 2:3-10
references.pmid: 11331434
references.citation: Toxicology. 2002 Dec 27;181-182:211-7
references.pmid: 12505313
references.citation: J Toxicol. 2012;2012:595307
references.pmid: 22523489
references.citation: Science. 2002 Jun 21;296(5576):2143-5
references.pmid: 12077387
references.citation: J Toxicol. 2012;2012:198793
references.pmid: 22523484
references.citation: Cancer Causes Control. 2003 May;14(4):303-10
references.pmid: 12846360
references.citation: Toxicol Appl Pharmacol. 2007 Jan 15;218(2):135-42
references.pmid: 17173945
references.citation: Toxicol Appl Pharmacol. 2014 Oct 1;280(1):53-9
references.pmid: 25062773
references.citation: Int J Hyg Environ Health. 2014 Jul;217(6):678-86
references.pmid: 24698386
references.citation: Environ Health Perspect. 2013 Jul;121(7):832-8
references.pmid: 23665672
references.citation: Environ Toxicol. 2011 Apr;26(2):118-23
references.pmid: 19768748
references.citation: J Occup Environ Med. 2003 Mar;45(3):241-8
references.pmid: 12661181
references.citation: Nature. 2006 Dec 21;444(7122):1022-3
references.pmid: 17183309
references.citation: Toxicol Appl Pharmacol. 2004 Aug 1;198(3):327-35
references.pmid: 15276412
references.citation: Environ Health Perspect. 2010 Apr;118(4):533-8
references.pmid: 20064784
references.citation: Front Med. 2011 Dec;5(4):420-33
references.pmid: 22198754
references.citation: Hypertension. 1995 Jan;25(1):53-60
references.pmid: 7843753
references.citation: Environ Res. 2008 Nov;108(3):300-8
references.pmid: 18701095
references.citation: Environ Res. 2014 Jul;132:281-9
references.pmid: 24834823
references.citation: Cardiovasc Toxicol. 2005;5(1):29-41
references.pmid: 15738583
references.citation: Toxicol Appl Pharmacol. 2009 Sep 1;239(2):137-43
references.pmid: 19133283
references.citation: Environ Health Perspect. 2007 Jul;115(7):1081-6
references.pmid: 17637926
references.citation: Lancet. 2002 Nov 2;360(9343):1347-60
references.pmid: 12423980
references.citation: Environ Health Perspect. 2013 Mar;121(3):295-302
references.pmid: 23458756
references.citation: Toxicol Appl Pharmacol. 2011 Apr 15;252(2):176-82
references.pmid: 21320519
references.citation: Toxicol Appl Pharmacol. 2005 Aug 15;206(3):299-308
references.pmid: 16039941
references.citation: Toxicol Lett. 2011 Sep 10;205(3):250-6
references.pmid: 21708234
references.citation: Eur J Epidemiol. 2005;20(7):575-9
references.pmid: 16119429
references.citation: Am J Epidemiol. 2007 Mar 1;165(5):541-52
references.pmid: 17164464
references.citation: Environ Health Perspect. 2010 Jul;118(7):1004-9
references.pmid: 20603239
references.citation: Environ Health. 2013;12:37
references.pmid: 23602086